Cargando…
High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage
Background: The role of RASGRF2 has been verified in the development of various cancers. However, its roles in stomach adenocarcinoma (STAD) are still under investigation. Methods: RASGRF2 transcript-level data and the associated clinical information from patients with STAD were extracted from The C...
Autores principales: | Du, Yaqi, Wang, Zhengguang, Wan, Weina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558656/ https://www.ncbi.nlm.nih.gov/pubmed/34729119 http://dx.doi.org/10.7150/jca.63029 |
Ejemplares similares
-
High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis
por: Nakagawa, Tomoki, et al.
Publicado: (2021) -
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice
por: Morella, Ilaria, et al.
Publicado: (2022) -
RasGrf1 and Aging
por: Davies, Kelvin J. A., et al.
Publicado: (2011) -
Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma
por: Wang, Zhengguang, et al.
Publicado: (2022) -
Increased SEC23A Expression Correlates with Poor Prognosis and Immune Infiltration in Stomach Adenocarcinoma †
por: Zhaoran, Su, et al.
Publicado: (2023)